Femasys (FEMY) Net Margin (2020 - 2026)
Femasys' (FEMY) quarterly Net Margin came in at 1346.81% in Q2 2026, down 22630.0% on a YoY basis from N/an in Q2 2025, and down 20.2% quarter-over-quarter from 1120.52% in Q2 2025.
Powered by 
Analysis
Femasys (FEMY) Net Margin (2020 - 2026) Analysis & Trends
Femasys (FEMY) has reported Net Margin for 7 consecutive years, with 1346.81% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Net Margin fell 22630.0% year-over-year to 1346.81%; the trailing twelve-month figure through Jun 2026 stood at 1206.51% (down 9283.0% YoY), and the FY2025 full-year result was 812.27%, up 34276.0% from the prior year.
- Net Margin retreated to 1346.81% in Q2 2026 per FEMY's latest filing, from 1120.52% in the prior quarter.
- Across five years, Net Margin topped out at 858.48% in Q3 2022 and bottomed at 2115.08% in Q2 2024.
- Historically, Net Margin has averaged 1264.26% across 5 years, with a median of 1120.52% in 2025.
- The widest YoY moves for Net Margin: up 118856 bps in 2024, down 121231 bps in 2024.
- Over 5 years, Net Margin stood at 1235.55% in 2022, then plunged by 68 bps to 2069.56% in 2023, then surged by 57 bps to 881.0% in 2024, then retreated by 27 bps to 1120.52% in 2025, then slipped by 20 bps to 1346.81% in 2026.
- According to Business Quant data, Net Margin over the past three periods registered 1346.81%, 1120.52%, and 1727.94% for Q2 2026, Q2 2025, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 7.37% |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 28.46% |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 15.17% |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 19.37% |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 16.67% |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 13.87% |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | - |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 19.04% |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 13.47% |
| 10 | Femasys | 9.01 Mn | 7.57 Mn | 189,391.00 | -1,346.81% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,346.81% |
| Jun 30, 2025 | -1,120.52% |
| Mar 31, 2025 | -1,727.94% |
| Dec 31, 2024 | -881.00% |
| Sep 30, 2024 | -974.73% |
| Jun 30, 2024 | -2,115.08% |
| Mar 31, 2024 | -1,327.55% |
| Dec 31, 2023 | -2,069.56% |
| Sep 30, 2023 | -1,635.66% |
| Jun 30, 2023 | -902.77% |
| Mar 31, 2023 | -1,002.18% |
| Dec 31, 2022 | -1,235.55% |
| Sep 30, 2022 | -858.48% |
| Jun 30, 2022 | -869.02% |
| Mar 31, 2022 | -897.01% |
| Dec 31, 2021 | -929.85% |
| Sep 30, 2021 | -838.23% |
| Jun 30, 2021 | -332.22% |
| Mar 31, 2021 | -554.99% |
| Dec 31, 2020 | -590.65% |